Novo defends diversification push as CEO eyes deals beyond obesity

Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.

Loading


Leave a comment

Your email address will not be published. Required fields are marked *